3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Conditions
Leukemia, Myeloid, Acute
132
Myelodysplastic Syndromes
57
Leukemia
32
Leukemia, Myelomonocytic, Chronic
23
Recurrence
18
Lymphoma, Large B-Cell, Diffuse
10
Myeloproliferative Disorders
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Congenital Abnormalities
7
Primary Myelofibrosis
6
Melanoma
6
Hodgkin Disease
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Ovarian Neoplasms
5
Blast Crisis
5
Thrombocythemia, Essential
4
Polycythemia Vera
4
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma
4
Leukemia, Monocytic, Acute
4
Leukemia, Biphenotypic, Acute
4
Anemia, Refractory, with Excess of Blasts
4
Neoplasm Metastasis
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Myeloid, Accelerated Phase
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Interventions
Paclitaxel
1
Decitabine
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Primary Malignant Neoplasm of Ovary
×
Decitabine
×
Clear all
NCT02159820
2014-06-10
DAC and CT
Chinese PLA General Hospital
Phase 2/3
Unknown
500 enrolled